AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading ABBV News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.22%33.700.6%$935.67m
BMYBristol-Myers Squibb Company
2.46%56.130.8%$884.88m
JNJJohnson & Johnson
0.00%119.660.6%$880.91m
MRKMerck & Co., Inc.
-0.28%65.300.7%$665.15m
ABBVAbbVie, Inc.
0.15%61.921.9%$432.30m
LLYEli Lilly and Company
0.50%80.761.0%$316.52m
NVSNovartis AG Sponsored ADR
0.02%77.060.3%$275.66m
AZNAstraZeneca PLC Sponsored ADR
-0.19%28.961.0%$203.55m
GSKGlaxoSmithKline plc Sponsored ADR
-1.20%41.130.3%$158.88m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.16%35.320.2%$104.11m
SNYSanofi Sponsored ADR
-0.66%42.480.2%$68.42m
LCILannett Company, Inc.
0.78%22.7333.3%$26.82m
SCMPSucampo Pharmaceuticals, Inc. Class A
-2.58%12.2815.1%$11.32m
EPIXESSA Pharma Inc
2.22%2.300.0%$0.01m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.47%6.700.1%$0.01m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.